As of 2026-10-09, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (79.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -95287.8%.
The range of the Relative Valuation is (73.22) - (83.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.2x - 29.0x | 27.1x |
| Forward P/E multiples | 25.3x - 29.7x | 27.5x |
| Fair Price | (73.22) - (83.93) | (79.01) |
| Upside | -88314.4% - -101215.3% | -95287.8% |
| Date | P/E |